Recent statin use and cataract surgery

American Journal of Ophthalmology

Volumn 153, Issue 2, 2012, Pages

  Fong, Donald S ^a   Poon, Kwun Yee T ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CATARACT; CATARACT EXTRACTION; CAUCASIAN; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; TREATMENT DURATION;

EID: 84855999911     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.08.001     Document Type: Article

References (25)

1. World Health Organization Office of Information Blindness and Visual Disability: Part II: Major Causes Worldwide WHO fact sheet no 143 1997 WHO Geneva
2. M. Salm, D. Belsky, F.A. Sloan Trends in cost of major eye disease to Medicare, 1991 to 2000 Am J Ophthalmol 142 6 2006 976 982
3. J. Davignon, R. Laaksonen Low-density lipoprotein-independent effects of statins Curr Opin Lipidol 10 6 1999 543 559 (Pubitemid 30064025)
4. L. Smeeth, R. Hubbard, A.E. Fletcher Cataract and the use of statins: a case-control study Q J Med 96 5 2003 337 343 (Pubitemid 36592705)
5. B.E.K. Klein, R. Klein, K.E. Lee, L.M. Grady Statin use and incident nuclear cataract JAMA 295 23 2006 2752 2758
6. J.S.L. Tan, P. Mitchell, E. Rochtchina, J.J. Wang Statin use and the long term risk of incident cataract: The Blue Mountains Eye Study Am J Ophthalmol 143 4 2007 687 689 (Pubitemid 46452510)
7. G. Chodick, A.D. Heymann, S. Flash, E. Kokia, V. Shalev Persistence with statins and incident cataract: A population-based historical cohort study Ann Epidemiol 20 2 2010 136 142
8. A. Spector Oxidative stress-induced cataract; mechanism of action FASEB J 9 1995 1173 1182
9. M.M. Fernandez, N.A. Afshari Nutrition and the prevention of cataracts Curr Opin Ophthalmol 19 2008 66 70 (Pubitemid 350307564)
10. J. Horwitz Alpha-crystallin Eye Eye Res 76 2003 145 153 (Pubitemid 36266698)
11. K.G. Alberti, R.H. Eckel, S.M. Grundy Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
12. P.M. Kearney, L. Blackwell, R. Collins Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis Lancet 371 9607 2008 117 125
13. C. Sabanayagam, J.J. Wang, P. Mitchell Metabolic syndrome components and age-related cataract: the Singapore Malay eye study Invest Ophthalmol Vis Sci 52 5 2011 2397 2404
14. C. Galeone, E. Petracci, C. Pelucchi, A. Zucchetto, C. La Vecchia, A. Tavani Metabolic syndrome, its components and risk of age-related cataract extraction: a case-control study in Italy Ann Epidemiol 20 5 2010 380 384
15. J.S. Tan, J.J. Wang, P. Mitchell Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study Ophthalmic Epidemiol 15 5 2008 317 327
16. B.E. Lindblad, N. Hkansson, B. Philipson, A. Wolk Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women Ophthalmology 115 10 2008 1687 1692
17. F.M. Sacks, M.A. Pfeffer, L.A. Moye Cholesterol and Recurrent Event Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 14 1996 1001 1009 (Pubitemid 26338729)
18. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 19 1998 1349 1357
19. J. Davignon, R. Laaksonen Low-density lipoprotein-independent effects of statins Curr Opin Lipidol 10 6 1999 543 559 (Pubitemid 30064025)
20. Y. Kureishi, Z. Luo, I. Shiojima The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholeterolemic animals Nat Med 6 9 2000 1004 1010
21. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss AREDS report no. 9 Arch Ophthalmol 119 10 2001 1439 1452
22. Christen W.G., Manson J.E., Glynn R.J., et al. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol 1003;121(3):372-378.
23. J.J. Macneil, L. Robman, G. Tikellis, M.I. Sinclair, C.A. McCarty, H.R. Taylor Vitamin E supplementation and cataract: randomized controlled trial Ophthalmology 111 1 2004 75 84 (Pubitemid 38032213)
24. W.G. Hodge, J.P. Whitcher, W. Satariano Risk factors for age-related cataracts Epidemiol Rev 17 1995 336 346 (Pubitemid 26096878)
25. Age-Related Eye Disease Study Research Group Risk factors associated with age-related nuclear and cortical cataract: A case-control study in the age-related eye disease study, AREDS report no. 5 Ophthalmology 108 2001 1400 1408